ALGS vs PODD · rev $3.6M vs P/E 34, rev $2.07B
Aligos Therapeutics Inc (ALGS) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
ALGS currently screens at market cap $44.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the ALGS and PODD stock pages for the full models.
Not investment advice.